ID
BHC icon

Integral Derivatives’s Bausch Health BHC Stock Holding History

Integral Derivatives’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$293K Sell
18,400
-58,200
-76% -$1.08M 0.01% 513
2017
Q4 		$1.59M Buy
76,600
+22,000
+40% +$349K 0.03% 347
2017
Q3 		$782K Sell
54,600
-23,600
-30% -$357K 0.01% 581
2017
Q2 		$1.35M Buy
78,200
+35,700
+84% +$428K 0.03% 399
2017
Q1 		$469K Sell
42,500
-120,200
-74% -$1.65M 0.01% 761
2016
Q4 		$2.36M Buy
162,700
+57,600
+55% +$1.06M 0.04% 282
2016
Q3 		$2.58M Buy
105,100
+20,900
+25% +$541K 0.05% 214
2016
Q2 		$1.7M Buy
+84,200
New +$2.38M 0.04% 273
2016
Q1 		– Sell
-7,000
Closed -$712K – 867
2015
Q4 		$712K Buy
7,000
+2,900
+71% +$326K 0.02% 570
2015
Q3 		$731K Buy
4,100
+2,100
+105% +$490K 0.02% 604
2015
Q2 		$444K Sell
2,000
-9,800
-83% -$2.17M 0.01% 755
2015
Q1 		$2.34M Sell
11,800
-1,300
-10% -$231K 0.05% 253
2014
Q4 		$1.88M Buy
13,100
+5,600
+75% +$753K 0.03% 458
2014
Q3 		$984K Buy
7,500
+500
+7% +$59.6K 0.02% 717
2014
Q2 		$883K Sell
7,000
-4,400
-39% -$561K 0.02% 726
2014
Q1 		$1.5M Sell
11,400
-26,000
-70% -$3.56M 0.03% 519
2013
Q4 		$4.39M Buy
+37,400
New +$4.1M 0.06% 267

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Integral Derivatives's BHC Position: Q4 2017 in Review

Integral Derivatives sold out of Bausch Health (BHC) in Q4 2017, closing a stake of 34,053 shares — an estimated $540K sold.

Integral Derivatives first reported a position in BHC in Q2 2014 and held it in 10 quarters. The position peaked at $2.37M in Q4 2015. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2017.

  • Integral Derivatives reported no remaining Bausch Health position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 34,053 Bausch Health shares in Q4 2017, an estimated $540K.
  • Integral Derivatives first reported a position in Bausch Health in Q2 2014 and held it in 10 quarters.
  • Integral Derivatives's Bausch Health position peaked at $2.37M in Q4 2015.
  • 315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.